Reshma Kewalramani, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 23,378 shares at $305.06 ($7.1M) on 2022-08-15, disclosed to the SEC on 2022-08-17.
Open-market sale of $7.1M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $305.06 | 11,689 | $3.6M | 50.0% |
| 2 | $305.06 | 11,689 | $3.6M | 50.0% |
| Total | $305.06 avg | 23,378 | $7.1M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |